Investors & Media

SEC Filing Details

Document Details

Form
Filing Date
Aug 7, 2017
Document Date
Aug 2, 2017
Form Description

Statement of changes in beneficial ownership of securities

Filing Group
3,4,5
Company
bluebird bio, Inc.
Issuer
Genetix Pharmaceuticals Inc

Investor Contact

Manisha Pai

Sr. Director, Investor Relations

(617) 245-2107

investor@bluebirdbio.com

 

Media Contact

Elizabeth Pingpank

Associate Director, Corporate Communications

(617) 914-8736

EPingpank@bluebirdbio.com